Stoke Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SKORPIOS TRUST | 10/23/2024 | 8.91 M | $109.46 M | -17.87% | 15.81% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 5.57 M | $68.46 M | 100.00% | 9.89% |
| LYNX1 CAPITAL MANAGEMENT LP | 11/14/2024 | 5.19 M | $63.75 B | 0.04% | 9.21% |
| REDMILE GROUP, LLC | 11/14/2024 | 4.71 M | $57.93 M | -0.16% | 8.37% |
| RTW INVESTMENTS, LP | 11/14/2024 | 4.65 M | $57.18 M | 10.12% | 8.26% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 4.37 M | $53.69 M | 0.00% | 7.75% |
| MORGAN STANLEY | 11/14/2024 | 4.21 M | $51.68 M | 20.88% | 7.46% |
| COWEN AND COMPANY, LLC | 11/12/2024 | 3.24 M | $39.87 M | -3.60% | 5.76% |
| VANGUARD GROUP INC | 11/13/2024 | 2.76 M | $33.91 M | 2.66% | 4.90% |
| STATE STREET CORP | 11/14/2024 | 1.73 M | $21.25 M | 8.62% | 3.07% |
| MARSHALL WACE, LLP | 11/14/2024 | 1.67 M | $20.53 M | 43.90% | 2.97% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.39 M | $17.13 M | 1.92% | 2.47% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 1.31 M | $16.13 M | -10.61% | 2.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 870,831 | $10.70 M | 9.65% | 1.55% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 644,970 | $7.93 M | 7.78% | 1.14% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 479,452 | $5.89 M | 100.00% | 0.85% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 427,163 | $5.25 M | 0.00% | 0.76% |
| NORTHERN TRUST CORP | 11/13/2024 | 339,153 | $4.17 M | 20.01% | 0.60% |
| JANE STREET GROUP, LLC | 11/15/2024 | 330,442 | $4.06 M | 338.17% | 0.59% |
| FMR LLC | 11/13/2024 | 322,949 | $3.97 M | -18.86% | 0.57% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 316,134 | $3.89 M | 9.29% | 0.56% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 265,010 | $3.26 M | 38.49% | 0.47% |
| BIRCHVIEW CAPITAL, LP | 11/14/2024 | 210,000 | $2.58 M | 0.00% | 0.37% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 207,427 | $2.55 M | 0.00% | 0.37% |
| EXOME ASSET MANAGEMENT LLC | 12/13/2024 | 176,600 | $2.17 M | 100.00% | 0.31% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 171,246 | $2.10 M | 24.99% | 0.30% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 161,749 | $1.99 M | -9.95% | 0.29% |
| CHECKPOINT CAPITAL L.P. | 11/14/2024 | 157,514 | $1.94 M | 100.00% | 0.28% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 136,975 | $1.68 M | -4.64% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 134,141 | $1.65 M | 1,211.64% | 0.24% |
| PALO ALTO INVESTORS LP | 11/14/2024 | 125,861 | $1.55 M | 0.00% | 0.22% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 124,648 | $1.53 M | 27.45% | 0.22% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 123,149 | $1.51 M | -37.89% | 0.22% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 116,678 | $1.43 M | 1.54% | 0.21% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 112,667 | $1.38 M | 649.02% | 0.20% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 108,087 | $1.33 M | -42.31% | 0.19% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 11/04/2024 | 103,005 | $1.27 M | 54.28% | 0.18% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 101,774 | $1.25 M | 100.00% | 0.18% |
| ELEMENT CAPITAL MANAGEMENT LLC | 11/08/2024 | 96,380 | $1.18 M | 100.00% | 0.17% |
| WOODLINE PARTNERS LP | 11/14/2024 | 94,382 | $1.16 M | -5.79% | 0.17% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 91,865 | $1.13 M | -20.73% | 0.16% |
| GILDER GAGNON HOWE & CO LLC | 11/14/2024 | 90,755 | $1.12 M | 2.46% | 0.16% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 82,788 | $1.02 M | 3.63% | 0.15% |
| BARCLAYS PLC | 11/19/2024 | 79,740 | $980,000 | 145.35% | 0.14% |
| UBS GROUP AG | 11/14/2024 | 78,312 | $962,454 | -33.78% | 0.14% |
| FORT POINT CAPITAL PARTNERS LLC | 11/14/2024 | 75,429 | $927,022 | 0.00% | 0.13% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 75,089 | $922,843 | 100.00% | 0.13% |
| SWISS NATIONAL BANK | 11/07/2024 | 55,900 | $687,011 | -15.81% | 0.10% |
| EVERSEPT PARTNERS, LP | 11/14/2024 | 52,006 | $639,154 | -15.13% | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2024 | 49,900 | $613,271 | 100.00% | 0.09% |
Stoke Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 134 institutional investors and hedge funds held shares of Stoke Therapeutics, Inc.. The most heavily invested institutionals were:
Skorpios Trust: 8.91 M
BlackRock Funding, Inc. /DE: 5.57 M
Lynx1 Capital Management LP: 5.19 M
Redmile Group, LLC: 4.71 M
RTW INVESTMENTS, LP: 4.65 M
BAKER BROS. ADVISORS LP: 4.37 M
103.33% of Stoke Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 78.53 M shares in the last 24 months. This purchase volume represents approximately $841.07 M in transactions.